Useful documents

Duration of antibiotic treatments

After catheter removal and first negative blood culture

  • Coagulase-negative staphylococci without fever or endovascular material: 3 days
  • Streptococci, enterococci, and Gram-negative bacilli (GNB): 7 days
  • S. aureus: 14 days
  • If septic thrombophlebitis: 21 days
  • Yeasts: 14 days

If catheter preservation attempted (streptococci, enterococci, GNB, coagulase-negative staphylococci)

  • Lock therapy PLUS systemic antibiotics: 10 days

Complete amputation without skin/soft tissue infection

  • 48 hours post-op

Complete amputation with skin/soft tissue infection

  • 7D post-op

Osteitis without amputation

  • 6 weeks

Cholecystitis

  • Perforated gallbladder or grade III: 3 days
  • Percutaneously drained, untreated surgically, or undrained: 7 days
  • Drained cholangitis: 3 days post-drainage

C. difficile infection

  • 10 days

Diarrhea

Adults

  • Traveler’s diarrhea: single dose OR 3D if fever or dysenteric syndrome

Children

  • Shigella/Campylobacter: 3 days 
  • Yersinia: 5 days
  • Salmonella (if treated): 5 days

Diverticulitis (after symptomatic treatment failure)

7 days

Infected ascitic fluid

  • 5 days

Liver abscess

  • 28 days

Peritonitis

Adults

  • Digestive perforation operated within 24h: <1 days (surgical prophylaxis)
  • Non-surgical appendicitis: 7 days
  • Localized peritonitis: 3 days
  • Generalized communautary  peritonitis: 4 days
  • Postoperative peritonitis: 8 days

Children

  • At least 5 days

Typhoid fever

  • Simple 7 days (fluoroquinolones) OR 5 days (azithromycin)

Enterococci

  • Native valve: 2 weeks dual therapy THEN 2 weeks monotherapy
  • Prosthetic valve: 2 weeks dual therapy THEN 2 weeks monotherapy
  • Native or prosthetic valve: 2 weeks if vancomycin + gentamicin (14 days)
  •  Amoxicillin + ceftriaxone effective ONLY on Enterococcus faecalis (6 weeksfor this combination)

Streptococcus S (MIC ≤ 0.125 mg/L)

  • Native valve: 2 weeks (dual therapy) or 4 weeks (monotherapy)
  • Prosthetic valve: 6 weeks

Streptococcus I/R (MIC > 0.125 mg/L)

  • Native valve: 2 weeks dual therapy then 2 weeks monotherapy
  • Prosthetic valve: 2 weeks dual therapy then 4 weeks monotherapy

S. aureus

  • Native valve: 4 weeks monotherapy
  • Prosthetic valve: 2 weeks triple therapy using rifampicin then 4 weeks dual therapy

Without microbiological documentation or clinical orientation

  • If hospitalized: Minimum 3 days, with discontinuation if no signs of severity AND the patient is stable AND afebrile for 48 hours AND under hospital observation for 24-48 hours (if neutropenia persists)
  • If outpatient: Discontinue when neutrophil count (PNN) > 500/mm3 (expected to be less than 7 days)

With microbiological documentation or clinical orientation

  • 7 days then discontinue if afebrile for more than 4 days, microbiological eradication and resolution of clinical signs of infection (adjust according to site/pathogen)

Arthritis

  • S. aureus: 6 weeks
  • Streptococci: 4 weeks
  • Gonococcus: 7 days

Hand arthritis, post-inoculation

  • Recent (<4 weeks): surgical washout, then 14 days

Spondylodiscitis

Adult

  • 6 weeks

Children

  • for septic arthritis: 14 days
  • for osteomyelitis: 3 weeks
  • for pelvic osteoarthritis, spondylodiscitis, and more severe osteoarthritis: 4 to 6 weeks

Brain abscess

  • 6 weeks (3 weeks if drained)

Listeria meningitis

  • 21 days

Meningococcal meningitis

  • 5 days

Pediatric meningitis

  • Group B Streptococcus: 14 days 
  • Haemophilus: 7 days
  • E. coli: 21 days

Pneumococcal meningitis

  • 10 days

Acute Otitis Media

Adults

  • General: 5 days 
  • Exception: 

Children

  • Under 2 years: 10 days 

Community-acquired acute pneumonia

  • Including parapneumonic effusion

Adults

  • If clinical improvement by day 3: 3 days
  • If no clinical improvement by day 3 but at day 5: 5 days
  • If no improvement at day 5 or hospitalized in ICU: 7 days

Chlidren

  • 5 days

COPD Exacerbations

  • 5 days

Healthcare-Associated Pneumonia or Ventilator-Associated Pneumonia

Except immunocompromised, empyema or abscess

  • 7 days

Legionellosis

  • General : 14 days (21 days if severe form or immunocompromised patient)
  • Exception Azithromycin: 5 days

Pertussis

  • Based on macrolide Azithromycin: 3 days
  • Clarithromycin: 7 days 
  • Other macrolides: 14 days

Purulent pleural effusion (after final drainage)

Adults

  • 15 days

Children

  • 2 weeks until 4 or 6 weeks

Sinusitis

Adults

  • Amoxicillin: 7 days

Children

  • Amoxicillin : 10 days

Streptococcal Pharyngitis (GAS)

  • Amoxicillin: 6 days
  • Penicillin allergy (non-severe): Cefixime 4 days
  • Severe beta-lactam allergy: Clarithromycin 5 days or Azithromycin 3 days

Complicated furuncle or animal bite

  • 5 days

Furunculosis, severe impetigo, non-necrotizing bacterial dermo-hypodermitis (cellulitis, erysipelas, etc.)

  • 7 days

GNB (Enterobacteriaceae, non-fermenters), streptococci, enterococci

  • 7 days

S. aureus & S. lugdunensis

  • 14 days

Complicated upper genital infections

  • Ceftriaxone until improvement (max 7 days) + doxycycline AND metronidazole 14 days

Early syphilis

  • Benzathine benzylpenicillin single dose
  • If allergic: doxycycline 14 days

Uncomplicated upper genital infections

  • Ceftriaxone until improvement (max 7 days) + doxycycline AND metronidazole 14 days

Urethritis and cervicitis

  • Ceftriaxone single dose + doxycycline 7 days (alternative: + azithromycin 1g orally once)

Acute cystitis

Adults

  • If Cotrimoxazole (based on antibiogramm) 5 days
  • If other molecule (note: avoid fluoroquinolones) 7 days

Children

  • If Cotrimoxazole (based on antibiogramm) 5 days
  • If other molecule (note: avoid fluoroquinolones) 7 days

Acute pyelonephritis

Adults

  • Fluoroquinolone or injectable beta-lactam: 7 days
  • Other molecules, severe pyelonephritis, or with risk of complications, healthcare-associated: 10 days

Children

  • 10 days

Male urinary tract infection with fever

  • 14 days

Male urinary tract infection without fever

  • 7 days

Download